• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    9.48 Up 0.47(5.22%) Dec 19, 4:00PM EST
    |After Hours : 9.48 0.00 (0.00%) Dec 19, 7:45PM EST
    Add to Portfolio
    Prev Close:9.01
    Open:8.99
    Bid:N/A
    Ask:9.48 x 100
    1y Target Est:21.00
    Beta:4.65
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:8.80 - 9.60
    52wk Range:7.48 - 15.80
    Volume:3,513,134
    Avg Vol (3m):1,156,050
    Market Cap:574.40M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INO

    Comparison

    Symbol% ChgMkt Cap
    INOUp 5.22%574.40M
    AZNDown 0.58%90.54B
    PFEDown 0.09%201.24B
    SNYDown 0.90%121.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):56.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.61
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback